“CLINICAL-PATOGENETIC RATIONALE FOR THE USE OF GLYCOSAMINOGLYCANS IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS”. Art of Medicine 28, no. 4 (December 10, 2023): 88–93. Accessed June 24, 2026. https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/1060.